300 related articles for article (PubMed ID: 32192612)
1. 'Have we missed reporting adverse drug reactions under Revised National TB Control Programme?' - A mixed method study in Bengaluru, India.
Krishnappa L; Gadicherla S; Chidambaram P; Anuradha HV; Somanna SN; Naik PR; Das A; Narasimhaiah S; Nagaraja SB
Indian J Tuberc; 2020 Jan; 67(1):20-28. PubMed ID: 32192612
[TBL] [Abstract][Full Text] [Related]
2. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
Adisa R; Omitogun TI
BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
4. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Tandon VR; Mahajan V; Khajuria V; Gillani Z
Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
[TBL] [Abstract][Full Text] [Related]
5. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
Hajj A; Hallit S; Ramia E; Salameh P;
Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
[TBL] [Abstract][Full Text] [Related]
6. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran.
Vessal G; Mardani Z; Mollai M
Pharm World Sci; 2009 Apr; 31(2):183-7. PubMed ID: 19116770
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: A pilot study.
Ahmad A; Patel I; Balkrishnan R; Mohanta GP; Manna PK
Perspect Clin Res; 2013 Oct; 4(4):204-10. PubMed ID: 24312887
[TBL] [Abstract][Full Text] [Related]
8. Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis.
Terblanche A; Meyer JC; Godman B; Summers RS
Hosp Pract (1995); 2017 Dec; 45(5):238-245. PubMed ID: 28914115
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
[TBL] [Abstract][Full Text] [Related]
10. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
11. Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment.
Sagwa EL; Souverein PC; Ribeiro I; Leufkens HG; Mantel-Teeuwisse AK
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):1-8. PubMed ID: 27868278
[TBL] [Abstract][Full Text] [Related]
12. Coping with tuberculosis and directly observed treatment: a qualitative study among patients from South India.
Yellappa V; Lefèvre P; Battaglioli T; Narayanan D; Van der Stuyft P
BMC Health Serv Res; 2016 Jul; 16():283. PubMed ID: 27430557
[TBL] [Abstract][Full Text] [Related]
13. Knowledge, attitude and practices associated with adverse drug reaction reporting amongst doctors in a teaching hospital.
Chopra D; Wardhan N; Rehan HS
Int J Risk Saf Med; 2011; 23(4):227-32. PubMed ID: 22156087
[TBL] [Abstract][Full Text] [Related]
14. Adverse drug reaction reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia.
Nadew SS; Beyene KG; Beza SW
PLoS One; 2020; 15(1):e0227712. PubMed ID: 31961883
[TBL] [Abstract][Full Text] [Related]
15. Knowledge, Attitude, and Practices regarding Pharmacovigilance and Adverse Drug Reaction reporting among Dental Students in a Teaching Hospital, Jodhpur, India: A Cross-sectional Study.
Chhabra KG; Sharma A; Chhabra C; Reddy JJ; Deolia SG; Mittal Y
J Contemp Dent Pract; 2017 Oct; 18(10):964-969. PubMed ID: 28989138
[TBL] [Abstract][Full Text] [Related]
16. Utilization of and barriers to public sector tuberculosis services in India.
Dandona R; Dandona L; Mishra A; Dhingra S; Venkatagopalakrishna K; Chauhan LS
Natl Med J India; 2004; 17(6):292-9. PubMed ID: 15736548
[TBL] [Abstract][Full Text] [Related]
17. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
[TBL] [Abstract][Full Text] [Related]
18. Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
Bhushan B; Chander R; Kajal NC; Ranga V; Gupta A; Bharti H
Indian J Tuberc; 2014 Oct; 61(4):318-24. PubMed ID: 25675695
[TBL] [Abstract][Full Text] [Related]
19. Strengthening the Bolivian pharmacovigilance system: New surveillance strategies to improve care for Chagas disease and tuberculosis.
Cortes-Serra N; Saravia R; Grágeda RM; Apaza A; González JA; Ríos B; Gascón J; Torrico F; Pinazo MJ
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008370. PubMed ID: 32956348
[TBL] [Abstract][Full Text] [Related]
20. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul.
Toklu HZ; Uysal MK
Pharm World Sci; 2008 Oct; 30(5):556-62. PubMed ID: 18350373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
